ArticleBMC cancer2025
Development and validation of a machine learning model to predict delays in seeking medical care among patients with breast cancer in China.
Article in BMC cancer, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
1 citing paper in PubMed.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
5 authors.
Funding
Abstract
backgroundDelays in seeking medical care may affect the survival rates of breast cancer patients. We aimed to explore potential risk factors for the delay in seeking medical care among breast cancer patients by constructing a highly effective machine learning (ML) prediction model.
methodsA cross-sectional methodology was utilized, and the demographic and clinical characteristics of 540 patients with breast cancer in Sichuan Cancer Hospital from July 2022 to June 2023 were collected to develop a model. Feature selection was performed using a Lasso algorithm, and six ML algorithms, including XGB, LR, RF, CNB, SVM and KNN, were applied for model construction. The k-fold cross-validation method was used for internal verification. And ROC curves, calibration curves, DCA and external validation were used for model evaluation. The SHAP method was used to interpret the model visualization.
resultsA comprehensive analysis was conducted in a cohort of 540 patients diagnosed with breast cancer, of whom 212 patients (39.26%) experienced a delay. The Lasso algorithm selected eight variables that were most suitable for model construction. The RF model demonstrated superior performance compared to the other five prediction models. The AUC values in the training set ROC, validation set ROC, and external verification ROC curves were 1.00, 0.86, and 0.76, respectively in RF model. The results of the calibration curves indicated that the calibration curves of the RF models closely resembled the ideal curves. The DCA curves exhibited a net clinical benefit in comparison to treatment for or treatment for none for all models, with the exception of CNB.
conclusionsThe machine learning algorithm utilized in this study effectively generated a prediction model for delays in seeking medical care for patients with breast cancer. The best RF model’s remarkable predictive power, exhibiting a good discrimination and calibration.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.